Antihypertensives Market Size, Share, Growth Rate, Global Industry Report 2032

Antihypertensives Market: Industry Perspective

The global antihypertensives market size was worth around USD 21.75 billion in 2023 and is predicted to grow to around USD 28.5 billion by 2032 with a compound annual growth rate (CAGR) of roughly 3.05% between 2024 and 2032.

Request Free Sample

The report covers forecasts and analyses for the antihypertensives market on a global and regional level. The study provides historical data from 2018 along with forecasts from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the antihypertensives market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the antihypertensives market on a global as well as regional level.

Request Free Sample

In order to give the users of this report a comprehensive view of the antihypertensives market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Antihypertensives Market: Overview

Drugs used for treating high blood pressure or hypertension are referred to as antihypertensives. The antihypertensive drug class is used to prevent complications associated with high blood pressure, like myocardial infarction and stroke. Research evidence suggests a decrease in hypertension-related risks like ischaemic heart disease, stroke, heart failure, dementia, and mortality by many folds using antihypertensive drugs. Large numbers of antihypertensive drug classes are used to reduce blood pressure. These include vasodilators, renin inhibitors, calcium channel blockers, alpha-blockers, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), diuretics, and others.

Antihypertensives Market: Growth Factors

The demand for the antihypertensives market is driven by the increasing prevalence of hypertension among adults of all age groups, the rise in prevalence of cardiovascular diseases, sedentary lifestyles, and changing eating habits across the globe. Also, the increasing geriatric population, increasing disposable income, and health awareness are other factors that boost the market growth.

An increasing number of generics and growing competition may act as a restraint to market growth. Emerging markets with an increasing geriatric population base and the launch of novel therapies are expected to bring new growth opportunities for major market players operating in the global antihypertensives.

Antihypertensives Market: Segmentation Analysis

Based on drug class, the global antihypertensives market is bifurcated into vasodilators, renin inhibitors, calcium channel blockers, alpha-blockers, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), diuretics and other drugs. The diuretics drug class segment held the largest market share in 2023. Diuretics are used as the first line of treatment for controlling high blood pressure and thus account for a large market share. Beta-blocker and calcium channel blockers drug classes will see rapid growth over the forecast period.

Antihypertensives Market: Report Scope

Antihypertensives Market: Regional Analysis

North America dominated the global antihypertensives market in 2023. The increasing prevalence of hypertension, increasing risk of related cardiovascular complications such as stroke, heart failure, ischemic heart disease, etc., growing awareness and increasing focus of major players to launch novel therapies with higher efficiency and lower side effects are factors driving the market in this region. Europe was the second largest regional market. The increasing geriatric population, presence of developed infrastructure, favorable reimbursement policies and increasing awareness and prevalence of hypertension are some of the factors that boost market growth in this region. Latin America is expected to witness moderate growth over the forecast period.

Asia Pacific region will exhibit highest growth for antihypertensives market in the coming years. Growing adoption of Western culture, sedentary lifestyle, changing eating habits, lack of physical activity, increasing geriatric population and rising prevalence of hypertension and related complications are factors promoting antihypertensives market growth in Asia Pacific. Middle East and Africa will see considerable growth in the coming years.

Antihypertensives Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key players in the antihypertensives market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the antihypertensives market on a global and regional basis.

The global antihypertensives market is dominated by players like:

• AstraZeneca Plc
• Johnson & Johnson Ltd.
• Lupin Limited
• Boehringer Ingelheim
• Merck & Co.
• Sanofi S.A.
• Novartis AG
• Pfizer Inc.
• Daiichi Sankyo Company Limited

The report segments of global antihypertensives market as follows:

Global Antihypertensives Market: By Drug Class

• Diuretics
• Angiotensin receptor blockers (ARBs)
• Angiotensin-converting enzyme (ACE) inhibitors
• Beta-blockers
• Alpha-blockers
• Calcium channel blockers
• Renin-inhibitors
• Vasodilators
• Other Drugs

Global Antihypertensives Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa